- Home
- INDO vs CCEL Comparison
INDO vs CCEL Comparison
Compare INDO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- CCEL
- Stock Information
- Founded
- INDO 2018
- CCEL 1989
- Country
- INDO Indonesia
- CCEL United States
- Employees
- INDO N/A
- CCEL N/A
- Industry
- INDO Oil & Gas Production
- CCEL Managed Health Care
- Sector
- INDO Energy
- CCEL Health Care
- Exchange
- INDO Nasdaq
- CCEL Nasdaq
- Market Cap
- INDO 48.4M
- CCEL 50.0M
- IPO Year
- INDO 2019
- CCEL 1997
- Fundamental
- Price
- INDO $2.72
- CCEL $8.43
- Analyst Decision
- INDO
- CCEL
- Analyst Count
- INDO 0
- CCEL 0
- Target Price
- INDO N/A
- CCEL N/A
- AVG Volume (30 Days)
- INDO 1.1M
- CCEL 39.4K
- Earning Date
- INDO 11-29-2024
- CCEL 11-26-2024
- Dividend Yield
- INDO N/A
- CCEL 2.97%
- EPS Growth
- INDO N/A
- CCEL N/A
- EPS
- INDO N/A
- CCEL N/A
- Revenue
- INDO $3,127,587.00
- CCEL $31,838,476.00
- Revenue This Year
- INDO N/A
- CCEL $3.97
- Revenue Next Year
- INDO N/A
- CCEL $0.91
- P/E Ratio
- INDO N/A
- CCEL N/A
- Revenue Growth
- INDO N/A
- CCEL 1.95
- 52 Week Low
- INDO $2.03
- CCEL $3.67
- 52 Week High
- INDO $6.65
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- INDO 33.79
- CCEL 62.23
- Support Level
- INDO $3.14
- CCEL $7.00
- Resistance Level
- INDO $4.55
- CCEL $9.43
- Average True Range (ATR)
- INDO 0.37
- CCEL 0.74
- MACD
- INDO -0.17
- CCEL 0.15
- Stochastic Oscillator
- INDO 0.54
- CCEL 72.45
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.